<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29233179</article-id>
<article-id pub-id-type="pmc">5727961</article-id>
<article-id pub-id-type="publisher-id">339</article-id>
<article-id pub-id-type="doi">10.1186/s13041-017-0339-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Immature morphological properties in subcellular-scale structures in the dentate gyrus of Schnurri-2 knockout mice: a model for schizophrenia and intellectual disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nakao</surname>
<given-names>Akito</given-names>
</name>
<address>
<email>nakaoa@fujita-hu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>Naoyuki</given-names>
</name>
<address>
<email>naomiyazaki@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohira</surname>
<given-names>Koji</given-names>
</name>
<address>
<email>kohira@mukogawa-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagihara</surname>
<given-names>Hideo</given-names>
</name>
<address>
<email>h-hagi@fujita-hu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takagi</surname>
<given-names>Tsuyoshi</given-names>
</name>
<address>
<email>ttakagi@inst-hsc.jp</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Usuda</surname>
<given-names>Nobuteru</given-names>
</name>
<address>
<email>usudakenbikyou@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishii</surname>
<given-names>Shunsuke</given-names>
</name>
<address>
<email>sishii@rtc.riken.jp</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murata</surname>
<given-names>Kazuyoshi</given-names>
</name>
<address>
<email>kazum@nips.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
<address>
<phone>81-562-93-9376</phone>
<email>miyakawa@fujita-hu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 798X</institution-id><institution-id institution-id-type="GRID">grid.256115.4</institution-id><institution>Division of Systems Medical Science, </institution><institution>Institute for Comprehensive Medical Science, Fujita Health University, </institution></institution-wrap>1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192 Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2272 1771</institution-id><institution-id institution-id-type="GRID">grid.467811.d</institution-id><institution>National Institute for Physiological Sciences, National Institutes of Natural Sciences, </institution></institution-wrap>Okazaki, Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.260338.c</institution-id><institution>Department of Food Science and Nutrition, </institution><institution>Mukogawa Women’s University, </institution></institution-wrap>Nishinomiya, Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.410836.8</institution-id><institution>Institute for Developmental Research, Aichi Human Service Center, </institution></institution-wrap>Kasugai, Japan </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000094465255</institution-id><institution-id institution-id-type="GRID">grid.7597.c</institution-id><institution>RIKEN Tsukuba Institute, </institution></institution-wrap>Tsukuba, Japan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 798X</institution-id><institution-id institution-id-type="GRID">grid.256115.4</institution-id><institution>Department of Anatomy II, </institution><institution>Fujita Health University School of Medicine, </institution></institution-wrap>Toyoake, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>12</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>60</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Accumulating evidence suggests that subcellular-scale structures such as dendritic spine and mitochondria may be involved in the pathogenesis/pathophysiology of schizophrenia and intellectual disability. Previously, we proposed mice lacking Schnurri-2 (Shn2; also called major histocompatibility complex [MHC]-binding protein 2 [MBP-2], or human immunodeficiency virus type I enhancer binding protein 2 [HIVEP2]) as a schizophrenia and intellectual disability model with mild chronic inflammation. In the mutants’ brains, there are increases in C4b and C1q genes, which are considered to mediate synapse elimination during postnatal development. However, morphological properties of subcellular-scale structures such as dendritic spine in Shn2 knockout (KO) mice remain unknown. In this study, we conducted three-dimensional morphological analyses in subcellular-scale structures in dentate gyrus granule cells of Shn2 KO mice by serial block-face scanning electron microscopy. Shn2 KO mice showed immature dendritic spine morphology characterized by increases in spine length and decreases in spine diameter. There was a non-significant tendency toward decrease in spine density of Shn2 KO mice over wild-type mice, and spine volume was indistinguishable between genotypes. Shn2 KO mice exhibited a significant reduction in GluR1 expression and a nominally significant decrease in SV2 expression, while PSD95 expression had a non-significant tendency to decrease in Shn2 KO mice. There were significant decreases in dendrite diameter, nuclear volume, and the number of constricted mitochondria in the mutants. Additionally, neuronal density was elevated in Shn2 KO mice. These results suggest that Shn2 KO mice serve as a unique tool for investigating morphological abnormalities of subcellular-scale structures in schizophrenia, intellectual disability, and its related disorders.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13041-017-0339-2) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Mouse model</kwd>
<kwd>Schizophrenia</kwd>
<kwd>Intellectual disability</kwd>
<kwd>3D electron microscopy</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id>
<institution>Ministry of Education, Culture, Sports, Science and Technology</institution>
</institution-wrap>
</funding-source>
<award-id>25242078</award-id>
<award-id>15H01297</award-id>
<award-id>16H06462</award-id>
<principal-award-recipient>
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Accumulating evidence suggests that abnormalities in subcellular-scale structures such as dendritic spine and mitochondria may be involved in the pathogenesis/pathophysiology of schizophrenia, bipolar disorder, autism spectrum disorder, and intellectual disability [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. Spines are morphologically and biochemically discrete compartments that protrude from dendrites [<xref ref-type="bibr" rid="CR5">5</xref>]. It has been reported that spine enlargement parallels long-term potentiation, whereas long-term depression is associated with spine shrinkage [<xref ref-type="bibr" rid="CR6">6</xref>]. Notably, psychiatric disorders such as schizophrenia, autism spectrum disorder, and intellectual disability have been reported to be accompanied by disruptions in dendritic spine shape, volume, or number [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Mitochondria play a central role in various cellular processes that include regulation of ATP production, intracellular Ca<sup>2+</sup> concentration, and redox homoeostasis [<xref ref-type="bibr" rid="CR7">7</xref>]. Through these functions, mitochondria control various neural processes [<xref ref-type="bibr" rid="CR8">8</xref>]. It has been suggested that mitochondrial dysfunction underlies the pathophysiology of schizophrenia, bipolar disorder, and intellectual disability [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p id="Par3">Schnurri-2 (Shn2; also called major histocompatibility complex [MHC]-binding protein 2 [MBP-2], human immunodeficiency virus type I enhancer binding protein 2 [HIVEP2], or c-myc intron binding protein 1 [MIBP1]) was originally identified as a nuclear factor-κB (NF-κB) site-binding protein that binds tightly to the enhancers of MHC genes in the MHC regions of chromosome 6 [<xref ref-type="bibr" rid="CR10">10</xref>]. Recent genome-wide association studies have identified a number of single-nucleotide polymorphisms in the MHC region associated with schizophrenia [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR15">15</xref>]. MHC class I proteins coded in this region are reported to play important roles in neural processes [<xref ref-type="bibr" rid="CR16">16</xref>]. Genes in the MHC regions often harbor NF-κB-binding sequences in their promoter regions. Shn2 constitutively binds to NF-κB-binding sites to suppress NF-κB-dependent gene expression [<xref ref-type="bibr" rid="CR17">17</xref>]. To induce an immune response, Shn2 detaches from the NF-κB-binding site, which then leads to the transcription of NF-κB target genes [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Accordingly, Shn2 knockout (KO) mice exhibit constitutive NF-κB activation in CD4<sup>+</sup> T cells [<xref ref-type="bibr" rid="CR19">19</xref>]. Shn2 is expressed in several brain regions including the hippocampus, cortex, and cerebellum [<xref ref-type="bibr" rid="CR10">10</xref>]. We have previously reported that Shn2 KO mice demonstrated mild, widespread brain inflammation characterized by the up-regulation of NF-κB-responsive genes and activation of astrocytes [<xref ref-type="bibr" rid="CR20">20</xref>]. Shn2 KO mice demonstrated multiple schizophrenia-related phenotypes, including behavioral abnormalities that resemble those of schizophrenics, transcriptome/proteome changes similar to those of postmortem schizophrenia patients, decreased parvalbumin and glutamic acid decarboxylase 67 levels, increased theta power on electroencephalograms, and a thinner cortex [<xref ref-type="bibr" rid="CR20">20</xref>]. Schizophrenic subjects are reported to have lower mRNA levels for Shn2 [<xref ref-type="bibr" rid="CR21">21</xref>]. More recently, whole exome sequencing studies demonstrated that nine individuals with intellectual disability have distinct de novo variants in HIVEP2, and they are diagnosed with “HIVEP2 syndrome” [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Patients with HIVEP2 syndrome exhibit intellectual disability and behavioral problems that include hyperactivity, attention-deficit disorder, aggression, anxiety, and autism spectrum disorders [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Granule cells of the dentate gyrus (DG) failed to mature in Shn2 KO mice, a proposed endophenotype of neuropsychiatric disorders [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Thus, the Shn2 KO mouse is an animal model for schizophrenia and intellectual disability that has good concept validity. In the brains of Shn2 KO mice, there are increases in C4b and C1q genes [<xref ref-type="bibr" rid="CR20">20</xref>], which are thought to mediate synapse elimination during postnatal development [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Up-regulation of C1q and C4 genes could be a potential interface between inflammation and synaptic dysfunctions. Taken together, it is of interest that the morphology of neuronal dendritic spines in Shn2 KO mice be investigated.</p>
<p id="Par4">Serial block-face (SBF) imaging is a novel scanning electron microscopy (SEM) technique that enables much more efficient acquisition of a series of ultrastructural sectional images than previous methods such as high-voltage transmission electron microscopy (TEM) and serial-section TEM [<xref ref-type="bibr" rid="CR28">28</xref>]. Imaging of neural tissues using SBF-SEM and three-dimensional reconstruction from serial EM images is a powerful technique for analyzing fine subcellular-scale structures [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In the present study, we used three-dimensional reconstruction based on SBF images from SBF-SEM to analyze morphology of subcellular-scale structures in DG granule cells in Shn2 KO mice.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Animals</title>
<p id="Par5">We used 10-week-old male Shn2 KO mice (<italic>n</italic> = 3) and their male wild-type (WT) littermates (<italic>n</italic> = 3). Mutant and WT mice were group housed in a room with a 12 h light/dark cycle (lights on at 7:00 a.m.), with access to food and water ad libitum. Room temperature was kept at 23 ± 2 °C. All procedures were approved by the Institutional Animal Care and Use Committee of Fujita Health University.</p>
</sec>
<sec id="Sec4">
<title>Preparation of DG samples for SBF-SEM</title>
<p id="Par6">Fixed brain samples were cut into 100-μm-thick slices with a DTK-1000 Microslicer (Dosaka EM, Kyoto, Japan), and the slices were processed largely in accordance with a combinatorial heavy metal staining protocol that has been released on the website of the National Center for Microscopy and Imaging Research (La Jolla, CA) (<ext-link ext-link-type="uri" xlink:href="https://ncmir.ucsd.edu/sbem-protocol">https://ncmir.ucsd.edu/sbem-protocol</ext-link>). This protocol was designed to enhance signal for backscattered electron imaging at low accelerating voltages. In brief, the tissue slices were further fixed with 2% paraformaldehyde and 2% glutaraldehyde in cacodylate buffer (0.15 M sodium cacodylate containing 2 mM CaCl<sub>2</sub>, pH 7.4) at 4 °C overnight. The slices were washed three times with cacodylate buffer, and then post-fixed with 2% aqueous osmium tetroxide containing 1.5% potassium ferrocyanide in cacodylate buffer for 1 h at 4 °C, filtered 1% thiocarbohydrazide solution for 20 min at room temperature, 2% osmium tetroxide solution for 30 min at room temperature, 1% aqueous uranyl acetate overnight at 4 °C, and Walton’s lead aspartate solution [<xref ref-type="bibr" rid="CR31">31</xref>] for 30 min at 60 °C. The slices were then dehydrated with a graded series of ethanol, and then were infiltrated with durcupan resin and polymerized at 60 °C for 3 days.</p>
</sec>
<sec id="Sec5">
<title>SBF-SEM</title>
<p id="Par7">Small pieces of block including glomerulus were trimmed and mounted on aluminum SBF-SEM specimen pins (Gatan, Pleasanton, CA) using CircuitWorks Conductive Epoxy (Chemtronics, Kennesaw, GA). The entire surface of the specimen was coated with a thin layer (20 nm thickness) of gold to dissipate the electric charge caused by electron-beam irradiation during SEM imaging. In this study, we used an SBF-SEM system in which an in-chamber ultramicrotome system (3View; Gatan Inc., Pleasanton, CA) was incorporated in a SEM (MERLIN, Carl Zeiss Microscopy, Jena, Germany). SBF-SEM images were acquired as reported previously [<xref ref-type="bibr" rid="CR32">32</xref>]. Briefly, SBF images were obtained every 50-nm depth with a backscattered electron detector at an acceleration voltage of 1.5 kV. Two different serial SEM images were recorded simultaneously. One is a large field of view image (123 μm × 246 μm) at low resolution (30 nm/pixel), including the granule cell layer used for analyses of nuclear volume and neuronal density. The other is a small field of view image (57 μm × 57 μm) at high resolution (7 nm/pixel) in the middle molecular layer (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1) used for detailed morphological analyses in dendrites. The contrast of the images was inversed.</p>
</sec>
<sec id="Sec6">
<title>Data processing for three-dimensional reconstruction</title>
<p id="Par8">After 2× binning of the images, the image stack was automatically aligned in a Fiji/ImageJ software package (<ext-link ext-link-type="uri" xlink:href="http://fiji.sc/Fiji">http://fiji.sc/Fiji</ext-link>) as described previously [<xref ref-type="bibr" rid="CR33">33</xref>]. Segmentation and three-dimensional reconstruction were carried out in Renovo Neural Inc. (Cleveland, OH) using Reconstruct software (<ext-link ext-link-type="uri" xlink:href="https://synapseweb.clm.utexas.edu">https://synapseweb.clm.utexas.edu</ext-link>). Length and volume were generated using Reconstruct software from tracings of the dendritic shaft, dendritic spine neck, dendritic spine head, or mitochondria. Spine length or volume is the sum of length or volume of the neck and head, respectively. Diameters were calculated geometrically from length and volume assuming that each dendritic shaft, spine, spine neck, or spine head was a simple cylinder. Images and movies for figures were generated using AMIRA 5.6 Software (FEI Visualization Science Group, Burlington, MA) in Maxnet Co., Ltd. (Tokyo, Japan).</p>
</sec>
<sec id="Sec7">
<title>Immunohistochemistry</title>
<p id="Par9">Immunohistochemical analysis was performed essentially the same as previously described [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Adult mice were deeply anesthetized and transcardially perfused with 4% paraformaldehyde in phosphate buffered saline (PBS). The brains were dissected, immersed overnight in the same fixative, and transferred to 30% sucrose in PBS for at least 3 days for cryoprotection. Brains were mounted in Tissue-Tek (Miles, Elkhart, IN), frozen, and cut into 8-μm-thick coronal sections using a microtome (CM1850; Leica Microsystems, Wetzlar, Germany). The sections were preincubated for 30 min at room temperature in 5% skim milk in PBS containing 0.05% Tween-20, and then incubated overnight at 4 °C in PBS containing the primary antibodies. We used the following primary antibodies: rabbit polyclonal antibody for GluR1 (AB1504; Millipore, Billerica, MA) and postsynaptic density 95 (PSD95) (51–6900, invitrogen, Carlsbad, CA), and mouse monoclonal antibody for synaptic vesicle 2 (SV2) (Developmental Studies Hybridoma Bank, Iowa City, IA). The antibody for GluR1 detected a single band of an expected size in Western blotting analysis using mouse brain lysates [<xref ref-type="bibr" rid="CR34">34</xref>]. Immunoreactivity to the antigen was visualized using Alexa488- or Alexa594-conjugated secondary antibodies (Molecular Probes, Eugene, OR). Nuclear staining was performed with Hoechst 33,258 (Polyscience, Warrington, PA). We used a confocal microscope (LSM 510 META; Zeiss, Göttingen, Germany) to obtain images of the stained sections. Quantification of the immunofluorescence intensities in the DG molecular layer was performed using ZEN software (Zeiss). To quantify the expression levels of synaptic proteins, we calculated average values of immunofluorescence for WT and Shn2 KO mice by using average values of immunofluorescence for each animal. Two or three sections from each animal were processed for quantification.</p>
</sec>
<sec id="Sec8">
<title>Data analysis</title>
<p id="Par10">Statistical analysis was conducted using SAS University Edition (SAS Institute, Cary, NC). Data were analyzed using Student’s <italic>t</italic>-test or Wilcoxon rank sum test.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Results</title>
<sec id="Sec10">
<title>Immature dendritic spine morphology in DG of Shn2 KO mice</title>
<p id="Par11">We evaluated the effects of deficiency of Shn2 on the morphology of dendrites in granule cells in the middle molecular layer of the dorsal DG using serial images obtained with SBF-SEM (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). Three-dimensional reconstruction of serial SEM images made it possible to visualize EM-quality ultrastructure of subcellular-scale structures. In Shn2 KO mice, thin dendrites with long and thin spines were apparent in granule cells in the middle molecular layer of the dorsal DG (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>–<xref ref-type="fig" rid="Fig1">d</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2 and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3, and Additional file 2: Movie S1 and Additional file 3: Movie S2). We then quantified the diameters of dendritic shaft and spine, spine density, spine length, spine volume, and postsynaptic density (PSD) area using three-dimensional reconstructed images of dendrites. Shn2 KO mice have decreased dendrite diameter compared with that of WT mice (<italic>P</italic> = 0.0035) (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). There was a non-significant tendency toward decrease in spine density per 1 μm of dendritic shaft of Shn2 KO mice (<italic>P</italic> = 0.0929) (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). PSD area was indistinguishable between Shn2 KO and WT mice (<italic>P</italic> = 0.3060) (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). The spine length of Shn2 KO mice increased over WT mice (<italic>P</italic> = 0.0004), which was mainly due to an increase in spine neck length in Shn2 KO mice (<italic>P</italic> &lt; 0.0001) (Fig. <xref ref-type="fig" rid="Fig2">2d</xref>–<xref ref-type="fig" rid="Fig2">f</xref>). Spine diameter and spine neck diameter of Shn2 KO mice were significantly lower than those of WT mice (<italic>P</italic> = 0.0050, and <italic>P</italic> &lt; 0.0001, respectively) (Fig. <xref ref-type="fig" rid="Fig2">2g</xref>–<xref ref-type="fig" rid="Fig2">i</xref>). There was no significant difference between Shn2 KO and WT mice in terms of spine volume (Fig. <xref ref-type="fig" rid="Fig2">2j</xref>–<xref ref-type="fig" rid="Fig2">l</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Three-dimensional reconstruction of dendrites in the DG of Shn2 KO mice. (<bold>a</bold>, <bold>b</bold>) SEM images obtained through SBF-SEM in WT (<bold>a</bold>) and Shn2 KO (<bold>b</bold>) mice. Purple shows a dendritic shaft. (<bold>c</bold>, <bold>d</bold>) Three-dimensional reconstructions of representative dendrites in WT (<bold>a</bold>) and Shn2 KO (<bold>b</bold>) mice. Scale bars: 1 μm. Representative spines are in insets. Numbers indicate the position of spines. Scale bars: 0.3 μm. Purple, green, yellow and pink illustrate the dendritic shaft, spine neck, spine head, and PSD, respectively</p></caption><graphic id="MO1" xlink:href="13041_2017_339_Fig1_HTML"></graphic></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Immature dendritic spine morphology in the DG in Shn2 KO mice. (<bold>a</bold>, <bold>b</bold>) Comparison of dendrite diameter (<bold>a</bold>) and spine density (<bold>b</bold>) in WT (<italic>n</italic> = 24 dendrites, 8 dendrites per each of 3 mice) and Shn2 KO mice (<italic>n</italic> = 24 dendrites, 8 dendrites per each of 3 mice). (<bold>c</bold>–<bold>l</bold>) Mean values of PSD area (<bold>c</bold>), spine length (<bold>d</bold>), spine neck length (<bold>e</bold>), spine head length (<bold>f</bold>), spine diameter (<bold>g</bold>), spine neck diameter (<bold>h</bold>), spine head diameter (<bold>i</bold>), spine volume (<bold>j</bold>), spine neck volume (<bold>k</bold>), and spine head volume (<bold>l</bold>) in WT (<italic>n</italic> = 547 spines from 24 dendrites, 8 dendrites per each of 3 mice) and Shn2 KO mice (<italic>n</italic> = 386 spines from 24 dendrites, 8 dendrites per each of 3 mice). The <italic>P</italic>-values were calculated using a Wilcoxon rank sum test</p></caption><graphic id="MO2" xlink:href="13041_2017_339_Fig2_HTML"></graphic></fig>
</p>
<p id="Par12">
<media id="MOESM2" xlink:href="13041_2017_339_MOESM2_ESM.mov"><caption><p>Additional file 2: Movie S1. A movie of three-dimensional rendering of an SBF-SEM dataset from DG in WT mouse. Purple, green, yellow, and pink illustrate the dendritic shaft, spine neck, spine head, and PSD, respectively. (MOV 8.69 mb)</p></caption></media>
</p>
<p id="Par13">
<media id="MOESM3" xlink:href="13041_2017_339_MOESM3_ESM.mov"><caption><p>Additional file 3: Movie S2. A movie of three-dimensional rendering of an SBF-SEM dataset from DG in Shn2 KO mouse. Purple, green, yellow, and pink illustrate dendritic shaft, spine neck, spine head, and PSD, respectively. (MOV 9315 kb)</p></caption></media>
</p>
</sec>
<sec id="Sec11">
<title>Decreased expression levels of synaptic proteins in the DG of Shn2 KO mice</title>
<p id="Par14">Since Shn2 KO mice showed abnormalities in spine morphology, we then conducted immunofluorescence analyses using laser scanning confocal microscopy to evaluate expression levels of synaptic proteins, such as SV2, GluR1, and PSD95, in hippocampal regions in Shn2 KO mice (Fig. <xref ref-type="fig" rid="Fig3">3</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4). In the middle molecular layer of the DG, in which SBF-SEM analyses were conducted, Shn2 KO mice showed decreased expression levels of SV2 (<italic>P</italic> = 0.0483) and GluR1 (<italic>P</italic> = 0.0009) compared with those in WT mice (Fig. <xref ref-type="fig" rid="Fig3">3a</xref> and <xref ref-type="fig" rid="Fig3">b</xref>). PSD95 expression in the middle molecular layer had a non-significant tendency to decrease in Shn2 KO mice (<italic>P</italic> = 0.0936; Fig. <xref ref-type="fig" rid="Fig3">3c</xref>). In the inner molecular layer of Shn2 KO mice, expressions of SV2, GluR1, and PSD95 were significantly decreased (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4a–c; <italic>P</italic> = 0.0149, 0.0015, and 0.0481, respectively). In the outer molecular layer of Shn2 KO mice, GluR1 expression was significantly decreased (<italic>P</italic> = 0.0007; Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4e), while SV2 and PSD95 were not significantly different between Shn2 KO and WT mice (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4d and f; <italic>P</italic> = 0.0573 and 0.1024, respectively). In the CA1 radiatum layer, there were no significant differences between Shn2 KO and WT mice in the expression levels of SV2, GluR1, and PSD95 (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4g–i; <italic>P</italic> = 0.7262, 0.1435, and 0.8364, respectively). To avoid false-positive results caused by the multiple statistical tests performed, Bonferroni correction was applied to these results (the adjusted <italic>P</italic>-value at the 0.05 significance level for 12 indices was 0.004167). After the correction, the results remained significant for expression levels of GluR1 in the outer, middle, and inner molecular layers of the DG in Shn2 KO mice, while the other expression differences did not survive (Fig. <xref ref-type="fig" rid="Fig3">3</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4). These results demonstrated that Shn2 KO mice showed significantly decreased expression levels of GluR1 in the whole molecular layer, whereas there were nominally significant decreases in SV2 and PSD95 in specific regions of the molecular layer in the DG of Shn2 KO mice.<fig id="Fig3"><label>Fig. 3</label><caption><p>Decreased expression of GluR1 and a nominally significant decrease in SV2 expression in the middle molecular layer of the DG of Shn2 KO mice. (<bold>a</bold>–<bold>c</bold>) Representative images of SV2 (<bold>a</bold>), GluR1 (<bold>b</bold>), and PSD95 (<bold>c</bold>) staining in the DG of WT and Shn2 KO mice. Bar graphs represent fluorescence intensity normalized to that in the middle molecular layer in the DG of WT mice, and are presented as the mean ± SEM. For WT, <italic>n</italic> = 4 mice; for Shn2 KO, <italic>n</italic> = 4 mice. The <italic>P</italic>-values were calculated using Student’s <italic>t</italic>-test. Scale bar, 300 μm; g, granule cell layer; h, hilus; m, molecular layer</p></caption><graphic id="MO3" xlink:href="13041_2017_339_Fig3_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec12">
<title>Abnormal mitochondrial morphology in Shn2 KO mice</title>
<p id="Par15">SEM images show that filamentous mitochondria are found in dendritic shaft (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>), which is consistent with previous reports [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. SEM images and three-dimensional reconstruction of mitochondria suggested that ratios of constricted mitochondria to elongated ones were different between Shn2 KO and WT mice (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). We counted the number of constricted and elongated mitochondria whose volumes were greater than 0.1 μm<sup>3</sup>, since mitochondria whose volumes were less than 0.1 μm<sup>3</sup> demonstrated a spherical shape. In the mutants, the number of constricted mitochondria was decreased compared with those of WT (χ<sup>2</sup> = 6.9873, <italic>P</italic> = 0.0082) (Table <xref ref-type="table" rid="Tab1">1</xref>). Volumetric comparisons demonstrated that there were no significant differences between Shn2 KO and WT mice in mitochondria volume, mitochondria length, or mitochondria number per 1 μm of dendritic shaft (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5a–c; <italic>P</italic> = 0.7356, 0.1083, and 0.1703, respectively).<fig id="Fig4"><label>Fig. 4</label><caption><p>Abnormal mitochondrial morphology in Shn2 KO mice. (<bold>a</bold>, <bold>b</bold>) SEM images of mitochondria in WT (<bold>a</bold>) and Shn2 KO (<bold>b</bold>) mice. Red triangle indicates constriction in a mitochondrion. Scale bars, 1 μm. (<bold>c</bold>, <bold>d</bold>) Three-dimensional reconstruction of representative constricted mitochondrion in WT (<bold>c</bold>) and elongated mitochondrion in Shn2 KO (<bold>d</bold>) mice. Magenta shows a mitochondrion. Grey indicates dendritic shafts</p></caption><graphic id="MO4" xlink:href="13041_2017_339_Fig4_HTML"></graphic></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Abnormal mitochondrial morphology in Shn2 KO mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Constricted mitochondria</th><th>Elongated mitochondria</th><th>Total</th></tr></thead><tbody><tr><td>WT</td><td>27</td><td>33</td><td>60</td></tr><tr><td>Shn2 KO</td><td>8</td><td>33</td><td>41</td></tr><tr><td>Total</td><td>35</td><td>66</td><td>101</td></tr></tbody></table><table-wrap-foot><p>Cross tabulation of the number of constricted and elongated mitochondria in WT (<italic>n</italic> = 60 mitochondria from 24 dendrites, 8 dendrites per each of 3 mice) and Shn2 KO mice (<italic>n</italic> = 41 mitochondria from 24 dendrites, 8 dendrites per each of 3 mice). This cross tabulation yielded a significant chi-square value (χ<sup>2</sup> = 6.9873, <italic>P</italic> = 0.0082)</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec13">
<title>Decreased nuclear volume and increased neuronal density in Shn2 KO mice</title>
<p id="Par16">SEM images suggest decreased cell body size in the granule cell layer of DG in Shn2 KO mice (Fig. <xref ref-type="fig" rid="Fig5">5a</xref> and <xref ref-type="fig" rid="Fig5">b</xref>). To assess cell body size, nuclei of granule cells were reconstructed in three dimensions (Fig. <xref ref-type="fig" rid="Fig5">5c</xref> and <xref ref-type="fig" rid="Fig5">d</xref>). There was a significant decrease in nuclear volume in the mutants over WT mice (<italic>P</italic> &lt; 0.0001) (Fig. <xref ref-type="fig" rid="Fig5">5e</xref>). Neuronal density calculated from the number of nuclei was significantly increased in Shn2 KO mice compared with that in WT mice (<italic>P</italic> = 0.0007) (Fig. <xref ref-type="fig" rid="Fig5">5f</xref>), which is consistent with a previous report that cell-packing density was higher in the DG of Shn2 KO mice [<xref ref-type="bibr" rid="CR20">20</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>Decreased nuclear volume and increased neuronal density in Shn2 KO mice. (<bold>a</bold>, <bold>b</bold>) SEM images of cell bodies of granule cells in WT (<bold>a</bold>) and Shn2 KO (<bold>b</bold>) mice. Scale bars, 20 μm (<bold>c</bold>, <bold>d</bold>) Three-dimensional reconstruction of nuclear in granule cells of WT (<bold>c</bold>) and Shn2 KO (<bold>d</bold>) mice. (<bold>e</bold>) Comparison of neuronal density in WT (<italic>n</italic> = 3) and Shn2 KO (<italic>n</italic> = 3) mice. (<bold>f</bold>) Comparison of nuclear volume in WT (<italic>n</italic> = 120 from 3 mice) and Shn2 KO mice (<italic>n</italic> = 120 from 3 mice). The <italic>P</italic>-values were calculated using Student’s <italic>t</italic>-test (<bold>e</bold>) and Wilcoxon rank sum test (<bold>f</bold>)</p></caption><graphic id="MO5" xlink:href="13041_2017_339_Fig5_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion and conclusions</title>
<p id="Par17">Imaging of neural tissues using SBF-SEM and three-dimensional reconstruction from serial EM images is a powerful technique for analyzing subcellular-scale structures. Using this technique, we identified novel morphological phenotypes in Shn2 KO DG (a schematic is provided in Fig. <xref ref-type="fig" rid="Fig6">6</xref>). Shn2 KO mice have long and thin spines resembling immature spine-like structures called filopodia, which may later evolve into dendritic spines [<xref ref-type="bibr" rid="CR37">37</xref>]. Shn2 KO mice showed a significant reduction in GluR1 expression, and a nominally significant decrease in SV2 expression. PSD95 expression had a non-significant tendency to decrease in Shn2 KO mice, which is consistent with the finding of a non-significant tendency for decreased spine density in Shn2 KO mice compared with that in WT mice. The mutants exhibited decreased numbers of constricted mitochondria, suggesting that a balance between mitochondrial fusion and fission is compromised in Shn2 KO mice. Additionally, there were significant decreases in dendrite diameter and nuclear volume in the mutants. Neuronal density in Shn2 KO mice was increased compared with that in WT mice.<fig id="Fig6"><label>Fig. 6</label><caption><p>Schematic of morphological properties of subcellular-scale structures in DG of Shn2 KO mice</p></caption><graphic id="MO6" xlink:href="13041_2017_339_Fig6_HTML"></graphic></fig>
</p>
<p id="Par18">An “immature DG (iDG)” was first discovered in α-CaMKII<sup>+/−</sup> mice, which display abnormal behaviors related to schizophrenia, bipolar disorder, and other psychiatric disorders [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Previously, we have reported that Shn2 KO mice also possessed an iDG phenotype in terms of gene expression pattern and electrophysiological properties [<xref ref-type="bibr" rid="CR20">20</xref>]. The present study shows morphological immaturity of the dendritic spine in the DG of Shn2 KO mice, which is consistent with the idea that Shn2 KO mice have iDG phenotypes. Shn2 KO mice showed decreased expression levels of GluR1 in the entire molecular layer of the DG. GluR1 is expressed primarily in mature granule cells, and can be a potential marker for mature granule cells [<xref ref-type="bibr" rid="CR34">34</xref>]. It has been reported that GluR1 expression is reduced in the DG of α-CaMKII<sup>+/−</sup> mice [<xref ref-type="bibr" rid="CR34">34</xref>]. GluR1 reduction may be one of the shared changes among a subgroup of iDG mice. In the inner molecular layers of the DG in Shn2 KO mice, there were statistically significant reductions in GluR1 expression and nominally significant decreases in SV2 and PSD95, suggesting an altered number of synapses. Further SBF-SEM analysis is necessary to clarify the morphological changes in the inner molecular layer of the DG in Shn2 KO mice. Treatment with chronic fluoxetine—a selective serotonin reuptake inhibitor—reverses the neuronal maturation, resulting in the iDG phenotype [<xref ref-type="bibr" rid="CR39">39</xref>]. Kitahara et al. carried out a morphological analysis of synapses in the molecular layer of the DG after chronic fluoxetine treatment using focused ion beam-SEM [<xref ref-type="bibr" rid="CR40">40</xref>]. They showed that spine density is indistinguishable between chronic fluoxetine treatment and placebo mice, which is consistent with the result in Shn2 KO mice. While there was no significant difference between Shn2 KO and WT mice in spine volume and PSD area, chronic fluoxetine treatment increased spine and PSD volume compared with placebo mice. Further studies are required to investigate the effects of shared and unshared morphological changes among iDG mice in dendritic spines on neuronal function.</p>
<p id="Par19">We previously showed significant increases in expression level of genes involved in immune responses, such as complement genes in Shn2 KO mice [<xref ref-type="bibr" rid="CR20">20</xref>]. Notably, C1qa, C1qb, C1qc, and C4 were up-regulated in the brains of Shn2 KO mice. Complement proteins are widely expressed in neurons and glia in postnatal brain, and they play an important role in a process critical for establishing precise synaptic circuits [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Sekar et al. reported that association of schizophrenia with the MHC locus arises in part from many structurally diverse alleles of C4 genes, and expression of those genes is increased in post-mortem brains of schizophrenic patients [<xref ref-type="bibr" rid="CR26">26</xref>]. They proposed that excessive complement activity might explain the reduced number of synapses in brains of individuals with schizophrenia. In addition, our previous study showed decreased gene expression of kalirin in the DG of Shn2 KO mice [<xref ref-type="bibr" rid="CR20">20</xref>]. Kalirin is a schizophrenia-associated gene, and loss of kalirin correlates with decreased spine density in prefrontal cortex neurons [<xref ref-type="bibr" rid="CR3">3</xref>]. However, spine density was statistically indistinguishable between Shn2 KO and WT mice. It is noteworthy that the level of brain-derived neurotrophic factor (BDNF)—a neurotrophin protein—is increased in the DG of Shn2 KO mice [<xref ref-type="bibr" rid="CR42">42</xref>]. BDNF stimulation is reported to increase the density of dendritic filopodia and spines [<xref ref-type="bibr" rid="CR43">43</xref>]. It is possible that Shn2 KO mice have an enhanced turnover of spines due to an increase in expression of BDNF. Interestingly, patients with fragile X syndrome, intellectual disability-related diseases, exhibited an immature dendritic spine morphology and an increased dendritic spine density, suggesting enhanced spine turnover [<xref ref-type="bibr" rid="CR44">44</xref>]. It has been reported that Fmr1 KO mice, a fragile X syndrome mouse model, displayed enhanced spine turnover [<xref ref-type="bibr" rid="CR45">45</xref>]. Dendritic spine morphology in Shn2 KO DG neurons recapitulates that seen in fragile X syndrome. Thus, the Shn2 KO mouse may be a good model for investigating spine morphology in intellectual disability.</p>
<p id="Par20">It is thought that mitochondrial dysfunction may underlie the pathophysiology of schizophrenia, bipolar disorder, and intellectual disability [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Shn2 KO mice exhibited a decreased number of constricted mitochondria over WT mice, suggesting that a balance between mitochondrial fusion and fission is compromised in the mutants. Interestingly, Zhao and Li showed that lack of dysbindin, a schizophrenia susceptibility gene [<xref ref-type="bibr" rid="CR46">46</xref>], increased mitochondrial fission through dynamin-related protein 1 [<xref ref-type="bibr" rid="CR47">47</xref>]. Mitochondrial fission and fusion play critical roles in maintaining functional mitochondria when cells experience metabolic or environmental stresses [<xref ref-type="bibr" rid="CR48">48</xref>]. In the DG of Shn2 KO mice, genechip analysis demonstrated altered gene expression related to energy metabolism such as aldo-keto reductase genes <italic>Akr1c18</italic>, ATP-related genes (<italic>Atp2a</italic>, <italic>Atp2b</italic>, <italic>Atp6v,</italic> and <italic>Atp11c</italic>), the cytochrome-related gene <italic>Cyb561</italic>, and the phosphoglycerate-related gene <italic>Phgdh</italic> [<xref ref-type="bibr" rid="CR20">20</xref>]. Changes in protein amounts were also found in energy metabolism-related molecules, including aldo-keto reductase genes <italic>Akr1b3</italic>, ATP-related genes (<italic>Atp5a</italic>, <italic>Atp5d</italic>, <italic>Atp5f</italic>, <italic>Atp5k</italic>, and <italic>Atp6v</italic>), cytochrome-related genes (<italic>Uqcrfs1</italic>, <italic>Ubcrc2</italic>, <italic>Cox5b</italic>, <italic>Uqcrb</italic>, and <italic>Uchl1</italic>), the NADH dehydrogenase gene <italic>Ndufa10</italic>, and the phosphoglycerate-related gene <italic>Pgk1</italic> in the DG of Shn2 KO mice [<xref ref-type="bibr" rid="CR20">20</xref>]. These gene/protein expression changes may be related to abnormal mitochondrial morphology in Shn2 KO mice. Further studies are needed to investigate the relationships between morphological abnormality of mitochondria and energy metabolism-related gene/protein expression changes in Shn2 KO mice. Recently, we reported that significantly lower pH and higher lactate levels were observed in brains of mouse models for psychiatric disorders, including Shn2 KO mice, as well as a significant negative correlation between pH and lactate levels [<xref ref-type="bibr" rid="CR49">49</xref>]. We proposed that elevated glycolysis underlies increases in lactate levels, which is similar to the Warburg effect. Taken together, metabolism in Shn2 KO mice may be compromised due to abnormal mitochondrial morphology and metabolism-related gene/protein expression changes. It is possible that morphological abnormality in mitochondria is one of the shared endophenotypes in subgroups of psychiatric disorders.</p>
<p id="Par21">Shn2 KO mice showed decreased nuclear volume in DG. In Shn2 KO mice, adult neurogenesis is enhanced in DG (Hagihara et al.<italic>,</italic> unpublished observation). The present study confirmed that neuronal density in Shn2 KO mice was increased compared with that in WT mice, which is consistent with a previous report [<xref ref-type="bibr" rid="CR20">20</xref>]. It is possible that decreased nuclear volume in the DG of Shn2 KO mice may be due to increased neuronal density caused by enhanced neurogenesis. Our results are consistent with previous reports that show reduced hippocampal neuronal size in postmortem brains of schizophrenia patients [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
<p id="Par22">Taken together, morphological changes in Shn2 KO DG neurons recapitulate some aspects of morphological changes in psychiatric disorders such as schizophrenia and intellectual disability. Thus, Shn2 KO mice serve as a unique tool for investigating morphological abnormalities of subcellular-scale structures in those disorders and their related diseases.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec15">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13041_2017_339_MOESM1_ESM.doc"><label>Additional file 1:</label><caption><p>
<bold>Figure S1.</bold> Analysis area of the middle molecular layer of the dorsal DG for SBF-SEM imaging. (a) A schematic of the sampling area (red square) at a distance of approximately 100 μm from the upper blade of the granule cell layer. OML, outer molecular layer; MML, middle molecular layer; IML, inner molecular layer; GCL, granule cell layer. (b) Boxed regions indicate the tissue area sampled used for detailed morphological analyses in the dendrites in three WT mice and three Shn2 KO mice. Scale bar: 100 μm. <bold>Figure S2.</bold> Three-dimensional reconstruction of all dendrites for analysis in WT mice. Dendrite segments (white transparent) are illustrated with mitochondria (blue) and spines (head, orange; neck, green; PSD, magenta). Eight dendrites per each of three WT mice. <bold>Figure S3.</bold> Three-dimensional reconstruction of all dendrites for analysis in Shn2 KO mice. Dendrite segments (white transparent) are illustrated with mitochondria (blue) and spines (head, orange; neck, green; PSD, magenta). Eight dendrites per each of three Shn2 KO mice. <bold>Figure S4.</bold> Decreased expression levels of synaptic proteins in the DG of Shn2 KO mice (a–i) Bar graphs of SV2, GluR1, and PSD95 in the inner (a–c) and outer (d–f) molecular layers of the DG, and CA1 radiatum layer (d–f) represent fluorescence intensity normalized to that of WT mice, and are presented as the mean ± SEM. IML, inner molecular layer; OML, outer molecular layer; Rad, radiatum layer. For WT, n = 4 mice; for Shn2 KO, n = 4 mice. The <italic>P</italic>-values were calculated using Student’s <italic>t</italic>-test. <bold>Figure S5.</bold> Volumetric comparisons of mitochondria in WT and Shn2 KO mice. Comparison of mitochondria volume (a), mitochondria length (b), and mitochondria number per 1 μm of dendrite (c) in WT (n = 96 mitochondria from 24 dendrites, 8 dendrites per each of 3 mice) and Shn2 KO mice (n = 57 mitochondria from 24 dendrites, 8 dendrites per each of 3 mice). The <italic>P</italic>-values were calculated using Wilcoxon rank sum test. (DOC 8 mb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>BDNF</term>
<def>
<p id="Par230">Brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>DG</term>
<def>
<p id="Par231">Dentate gyrus</p>
</def>
</def-item>
<def-item>
<term>HIVEP2</term>
<def>
<p id="Par425">Human immunodeficiency virus type I enhancer binding protein 2</p>
</def>
</def-item>
<def-item>
<term>iDG</term>
<def>
<p id="Par521">Immature dentate gyrus</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p id="Par612">Knockout</p>
</def>
</def-item>
<def-item>
<term>MHC</term>
<def>
<p id="Par712">Major histocompatibility complex</p>
</def>
</def-item>
<def-item>
<term>NF-κB</term>
<def>
<p id="Par825">Nuclear factor-κB</p>
</def>
</def-item>
<def-item>
<term>PBS</term>
<def>
<p id="Par965">Phosphate buffered saline</p>
</def>
</def-item>
<def-item>
<term>PSD</term>
<def>
<p id="Par189">Postsynaptic density 26</p>
</def>
</def-item>
<def-item>
<term>PSD95</term>
<def>
<p id="Par181">Postsynaptic density 95</p>
</def>
</def-item>
<def-item>
<term>SBF-SEM</term>
<def>
<p id="Par182">serial block-face-scanning electron microscopy</p>
</def>
</def-item>
<def-item>
<term>Shn2</term>
<def>
<p id="Par183">Schnurri-2</p>
</def>
</def-item>
<def-item>
<term>SV2</term>
<def>
<p id="Par184">Synaptic vesicle 2</p>
</def>
</def-item>
<def-item>
<term>TEM</term>
<def>
<p id="Par185">Transmission electron microscopy</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s13041-017-0339-2) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<p>We thank W. Hasegawa, Y. Mobayashi, M. Murai, T. Murakami, M. Takeuchi, Y. Kagami, H. Mitsuya, A. Miyakawa, and other members of Miyakawa lab for their support, as well as S. Yamada for specimen preparation for SBF-SEM.</p>
<sec id="FPar1">
<title>Availability of data and materials</title>
<p id="Par23">The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec id="FPar2">
<title>Funding</title>
<p id="Par24">This research was supported by the Grant-in-Aid for Scientific Research (A) (25242078) and the Grant-in-Aid for Scientific Research on Innovative Areas “Unraveling the microendophenotypes of psychiatric disorders at the molecular, cellular and circuit levels” (15H01297) and “Dynamic regulation of brain function by Scrap &amp; Build system” (16H06462) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and by Advanced Bioimaging Support (ABiS) from the Grant-in-Aid for Scientific Research on Innovative Areas, Japan (to TM).</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>TM was responsible for the original concept and the overall design of the research. AN, NM, KO, and KM performed SBF-SEM analysis. HH performed immunohistochemical analysis. TT and SI provided Shn2 KO mice. AN, NU, and TM wrote the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval</title>
<p id="Par25">All procedures were approved by the Institutional Animal Care and Use Committee of Fujita Health University.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par26">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par27">TM received research grants from Astellas Pharma Inc. and Toyama Chemical Co., Ltd. Other authors have no conflict of interests to declare.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par28">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
</person-group>
<article-title>From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome</article-title>
<source/>Nat Rev Neurosci
          <year>2005</year>
<volume>6</volume>
<fpage>376</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1667</pub-id>
<pub-id pub-id-type="pmid">15861180</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis</article-title>
<source/>Hum Mol Genet
          <year>2005</year>
<volume>14</volume>
<fpage>241</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddi022</pub-id>
<pub-id pub-id-type="pmid">15563509</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>VanLeeuwen</surname>
<given-names>J-E</given-names>
</name>
<name>
<surname>Woolfrey</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>
<source/>Nat Neurosci
          <year>2011</year>
<volume>14</volume>
<fpage>285</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2741</pub-id>
<pub-id pub-id-type="pmid">21346746</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Swatton</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Huffaker</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>JT-J</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress</article-title>
<source/>Mol Psychiatry
          <year>2004</year>
<volume>9</volume>
<fpage>684</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001511</pub-id>
<pub-id pub-id-type="pmid">15098003</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Kater</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function</article-title>
<source/>Annu Rev Neurosci
          <year>1994</year>
<volume>17</volume>
<fpage>341</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ne.17.030194.002013</pub-id>
<pub-id pub-id-type="pmid">8210179</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashi-Takagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Structural dynamics of dendritic spines in memory and cognition</article-title>
<source/>Trends Neurosci
          <year>2010</year>
<volume>33</volume>
<fpage>121</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2010.01.001</pub-id>
<pub-id pub-id-type="pmid">20138375</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kann</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kovács</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Mitochondria and neuronal activity</article-title>
<source/>Am J Physiol - Cell Physiol
          <year>2007</year>
<volume>292</volume>
<fpage>C641</fpage>
<lpage>C657</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.00222.2006</pub-id>
<pub-id pub-id-type="pmid">17092996</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Mitochondria and neuroplasticity</article-title>
<source/>ASN Neuro
          <year>2010</year>
<volume>2</volume>
<fpage>AN20100019</fpage>
<pub-id pub-id-type="doi">10.1042/AN20100019</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: An overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci. Biobehav. Rev. 2014;46, Part 2:202–217.</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Iwaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Akieda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fukuchi</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of the biological functions of a transcription factor, c-myc intron binding protein 1 (MIBP1)</article-title>
<source/>J Biochem (Tokyo)
          <year>2002</year>
<volume>131</volume>
<fpage>349</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a003109</pub-id>
<pub-id pub-id-type="pmid">11872163</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>PF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>748</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">19571811</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Levinson</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Pe’er I, et al. common variants on chromosome 6p22.1 are associated with schizophrenia</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>753</fpage>
<lpage>757</lpage>
<pub-id pub-id-type="pmid">19571809</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common variants on 8p12 and 1q24.2 confer risk of schizophrenia</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<fpage>1224</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="doi">10.1038/ng.980</pub-id>
<pub-id pub-id-type="pmid">22037555</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ophoff</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Cichon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common variants conferring risk of schizophrenia</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>744</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">19571808</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>W-H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H-F</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L-D</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F-L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z-H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H-X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<fpage>1228</fpage>
<lpage>1231</lpage>
<pub-id pub-id-type="doi">10.1038/ng.979</pub-id>
<pub-id pub-id-type="pmid">22037552</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shatz</surname>
<given-names>CJMHC</given-names>
</name>
</person-group>
<article-title>Class I: an unexpected role in neuronal plasticity</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<fpage>40</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.044</pub-id>
<pub-id pub-id-type="pmid">19840547</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Boriek</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Nuclear factor-kappaB: its role in health and disease</article-title>
<source/>J Mol Med Berl Ger
          <year>2004</year>
<volume>82</volume>
<fpage>434</fpage>
<lpage>448</lpage>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Hosokawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iwamura</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Watarai</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of T helper type 2 cell differentiation by murine Schnurri-2</article-title>
<source/>J Exp Med
          <year>2005</year>
<volume>201</volume>
<fpage>397</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20040733</pub-id>
<pub-id pub-id-type="pmid">15699073</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Iwamura</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sugaya</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schnurri-2 controls memory Th1 and Th2 cell numbers in vivo</article-title>
<source/>J. Immunol. Baltim. Md 1950
          <year>2007</year>
<volume>178</volume>
<fpage>4926</fpage>
<lpage>4936</lpage>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficiency of Schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia</article-title>
<source/>Neuropsychopharmacology
          <year>2013</year>
<volume>38</volume>
<fpage>1409</fpage>
<lpage>1425</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2013.38</pub-id>
<pub-id pub-id-type="pmid">23389689</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. Molecular mechanisms and timing of cortical immune activation in schizophrenia. Am. J. Psychiatry. 2015;appi.ajp.2015.15010019.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schanze</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cremer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wieland</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Menzel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss-of-function variants in HIVEP2 are a cause of intellectual disability</article-title>
<source/>Eur J Hum Genet
          <year>2016</year>
<volume>24</volume>
<fpage>556</fpage>
<lpage>561</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2015.151</pub-id>
<pub-id pub-id-type="pmid">26153216</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinfeld</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Retterer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Danylchuk</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in HIVEP2 are associated with developmental delay, intellectual disability and dysmorphic features</article-title>
<source/>Neurogenetics
          <year>2016</year>
<volume>17</volume>
<fpage>159</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-016-0479-z</pub-id>
<pub-id pub-id-type="pmid">27003583</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Immature dentate gyrus: an endophenotype of neuropsychiatric disorders</article-title>
<source/>Neural Plast
          <year>2013</year>
<volume>2013</volume>
<fpage>318596</fpage>
<pub-id pub-id-type="doi">10.1155/2013/318596</pub-id>
<pub-id pub-id-type="pmid">23840971</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kajii</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Soma</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders</article-title>
<source/>Mol Brain
          <year>2008</year>
<volume>1</volume>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-1-6</pub-id>
<pub-id pub-id-type="pmid">18803808</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bialas</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>de Rivera</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Kamitaki</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>
<source/>Nature
          <year>2016</year>
<volume>530</volume>
<fpage>177</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1038/nature16549</pub-id>
<pub-id pub-id-type="pmid">26814963</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Christopherson</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The classical complement cascade mediates CNS synapse elimination</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>1164</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id>
<pub-id pub-id-type="pmid">18083105</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kremer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lippens</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bartunkova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asselbergh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blanpain</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fendrych</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Developing 3D SEM in a broad biological context</article-title>
<source/>J Microsc
          <year>2015</year>
<volume>259</volume>
<fpage>80</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1111/jmi.12211</pub-id>
<pub-id pub-id-type="pmid">25623622</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denk</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Horstmann</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Serial block-face scanning electron microscopy to reconstruct three-dimensional tissue nanostructure</article-title>
<source/>PLoS Biol
          <year>2004</year>
<volume>2</volume>
<fpage>e329</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0020329</pub-id>
<pub-id pub-id-type="pmid">15514700</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaito</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Maruo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple roles of afadin in the ultrastructural morphogenesis of mouse hippocampal mossy fiber synapses</article-title>
<source/>J Comp Neurol
          <year>2017</year>
<volume>525</volume>
<fpage>2719</fpage>
<lpage>2734</lpage>
<pub-id pub-id-type="doi">10.1002/cne.24238</pub-id>
<pub-id pub-id-type="pmid">28498492</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Lead asparate, an en bloc contrast stain particularly useful for ultrastructural enzymology</article-title>
<source/>J Histochem Cytochem
          <year>1979</year>
<volume>27</volume>
<fpage>1337</fpage>
<lpage>1342</lpage>
<pub-id pub-id-type="doi">10.1177/27.10.512319</pub-id>
<pub-id pub-id-type="pmid">512319</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Esaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Serial block-face scanning electron microscopy for three-dimensional analysis of morphological changes in mitochondria regulated by Cdc48p/p97 ATPase</article-title>
<source/>J Struct Biol
          <year>2014</year>
<volume>187</volume>
<fpage>187</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsb.2014.05.010</pub-id>
<pub-id pub-id-type="pmid">24893221</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yasuo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Physical association between a novel plasma-membrane structure and centrosome orients cell division</article-title>
<source/>elife
          <year>2016</year>
<volume>5</volume>
<fpage>e16550</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.16550</pub-id>
<pub-id pub-id-type="pmid">27502556</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Expression of the AMPA receptor subunits GluR1 and GluR2 is associated with granule cell maturation in the dentate gyrus</article-title>
<source/>Front Neurogenesis
          <year>2011</year>
<volume>5</volume>
<fpage>100</fpage>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kislin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sword</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fomitcheva</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Croom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pryazhnikov</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lihavainen</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reversible disruption of neuronal mitochondria by ischemic and traumatic injury revealed by quantitative two-photon imaging in the neocortex of anesthetized mice</article-title>
<source/>J Neurosci
          <year>2017</year>
<volume>37</volume>
<fpage>333</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1510-16.2016</pub-id>
<pub-id pub-id-type="pmid">28077713</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Medvedev</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Mitochondria form a filamentous reticular network in hippocampal dendrites but are present as discrete bodies in axons: a three-dimensional ultrastructural study</article-title>
<source/>J Comp Neurol
          <year>2005</year>
<volume>492</volume>
<fpage>50</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1002/cne.20682</pub-id>
<pub-id pub-id-type="pmid">16175555</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziv</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Evidence for a role of dendritic filopodia in synaptogenesis and spine formation</article-title>
<source/>Neuron
          <year>1996</year>
<volume>17</volume>
<fpage>91</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80283-4</pub-id>
<pub-id pub-id-type="pmid">8755481</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kamitani</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circadian gene circuitry predicts hyperactive behavior in a mood disorder mouse model</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>14</volume>
<fpage>2784</fpage>
<lpage>2796</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.067</pub-id>
<pub-id pub-id-type="pmid">27028761</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Haneda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reversal of hippocampal neuronal maturation by serotonergic antidepressants</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>8434</fpage>
<lpage>8439</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0912690107</pub-id>
<pub-id pub-id-type="pmid">20404165</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<mixed-citation publication-type="other">Kitahara Y, Ohta K, Hasuo H, Shuto T, Kuroiwa M, Sotogaku N, et al. Chronic fluoxetine induces the enlargement of perforant path-granule cell synapses in the mouse dentate gyrus. PLoS ONE [Internet]. 2016 [cited 2016 Apr 27];11. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720354/">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720354/</ext-link></mixed-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephan</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The complement system: an unexpected role in synaptic pruning during development and disease</article-title>
<source/>Annu Rev Neurosci
          <year>2012</year>
<volume>35</volume>
<fpage>369</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113810</pub-id>
<pub-id pub-id-type="pmid">22715882</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<mixed-citation publication-type="other">Koshimizu H, Ohira K, Hagihara H, Takao K, Takagi T, Kataoka M, et al. Dysregulation of BDNF-MAPK signaling pathway in the hippocampus of mice with “immature dentate gyrus”. SfN Meet. Abstr. 2013;</mixed-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>TrkB signaling modulates spine density and morphology independent of dendrite structure in cultured neonatal purkinje cells</article-title>
<source/>J Neurosci
          <year>1998</year>
<volume>18</volume>
<fpage>8559</fpage>
<lpage>8570</lpage>
<pub-id pub-id-type="pmid">9786964</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irwin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Galvez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
</person-group>
<article-title>Dendritic spine structural anomalies in fragile-X mental retardation syndrome</article-title>
<source/>Cereb Cortex
          <year>2000</year>
<volume>10</volume>
<fpage>1038</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/10.10.1038</pub-id>
<pub-id pub-id-type="pmid">11007554</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aldridge</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>W-B</given-names>
</name>
</person-group>
<article-title>Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome</article-title>
<source/>Proc Natl Acad Sci
          <year>2010</year>
<volume>107</volume>
<fpage>17768</fpage>
<lpage>17773</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1012496107</pub-id>
<pub-id pub-id-type="pmid">20861447</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Thiselton</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>The dystrobrevin-binding protein 1 gene: features and networks</article-title>
<source/>Mol Psychiatry
          <year>2008</year>
<volume>14</volume>
<fpage>18</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2008.88</pub-id>
<pub-id pub-id-type="pmid">18663367</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
</person-group>
<source/>Dysbindin regulates mitochondrial fission in hippocampal excitatory neurons through the dynamin-like-protein DLP1
          <year>2016</year>
<publisher-loc>Abstr</publisher-loc>
<publisher-name>SfN Meet</publisher-name>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youle</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Bliek</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Van der. Mitochondrial fission, fusion, and stress</article-title>
<source/>Science
          <year>2012</year>
<volume>337</volume>
<fpage>1062</fpage>
<lpage>1065</lpage>
<pub-id pub-id-type="doi">10.1126/science.1219855</pub-id>
<pub-id pub-id-type="pmid">22936770</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<mixed-citation publication-type="other">Hagihara H, Catts VS, Katayama Y, Shoji H, Takagi T, Huang FL, et al. Decreased brain pH as a shared endophenotype of psychiatric disorders. Neuropsychopharmacology [Internet]. 2017 [cited 2017 Aug 9]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/npp/journal/vaop/naam/abs/npp2017167a.html">http://www.nature.com/npp/journal/vaop/naam/abs/npp2017167a.html</ext-link>.</mixed-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinberger</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Cell biology of the hippocampal formation in schizophrenia</article-title>
<source/>Biol Psychiatry
          <year>1999</year>
<volume>45</volume>
<fpage>395</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(98)00331-X</pub-id>
<pub-id pub-id-type="pmid">10071707</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>